share_log

NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN

NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN

NUTEX HEALTH在威斯康辛州开设了密尔沃基急诊医院,这是其在该州的第二家分店。
PR Newswire ·  11/18 18:30

NUTEX HEALTH CONTINUES TO EXPAND ITS NATIONAL FOOTPRINT WITH ITS THIRD HOSPITAL OPENING IN 2024

Nutex Health继续扩大其全国足迹,预计在2024年开设第三家医院。

HOUSTON, Nov. 18, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of Milwaukee ER & Hospital, located at 1751 W Layton Ave, Milwaukee, WI 53221.

休斯顿,2024年11月18日 /PRNewswire/ -- Nutex Health Inc.("Nutex Health"或"公司")(纳斯达克:NUTX),是一家以医生为主导的综合医疗服务系统,在十个州设有23家先进的微型医院和医院门诊部(HOPD),并拥有以初级医疗为中心、具有风险承担能力的医生网络,今天宣布在威斯康星州密尔沃基市开设密尔沃基急救中心暨医院,地址为密尔沃基州莱顿大道西1751号,邮政编码53221。

The staff of medical experts at Milwaukee ER & Hospital are bringing the community 24/7/365 days of concierge-level care. The 20,000 square foot state-of-the-art facility houses 8 emergency room beds, 6 inpatient beds, one procedure room, an in-house pharmacy, laboratory services, and imaging, including MRI, CT scan, X-ray, and Ultrasound.

密尔沃基急救中心暨医院的医疗专家团队为社区提供24/7/365天的礼宾级护理。这座20,000平方英尺的先进设施设有8张急诊室病床、6张住院病床、一个手术室、一个内部药房、实验室服务以及影像学检查,包括MRI、CT扫描、X光和超声波检查。

"Our expert team of emergency physicians looks forward to showing each patient individualized, excellent care," stated Michaela Wood, M.D., Chief Medical Officer at Milwaukee ER & Hospital.

“我们的急救医生专家团队期待为每位患者提供个性化、优质的护理,”密尔沃基急救中心暨医院首席医疗官Michaela Wood万.D.表示。

Patients will be met with the convenience of emergency care in the comfort of a relaxing environment, a short wait, and ample one-on-one time with a board-certified physician. No matter the injury or illness a patient presents, Milwaukee ER & Hospital is equipped to treat patients efficiently and effectively.

患者将享受到在舒适环境中接受急救护理的便利,等待时间短,并能与经过认证的医生进行充分的一对一交流。无论患者呈现何种伤病,密尔沃基急救中心暨医院都能够高效、有效地治疗患者。

Following the opening of Green Bay ER & Hospital in Green Bay, Wisconsin and Post Falls ER & Hospital in Post Falls, Idaho, this is the Company's third opening of 2024,

在威斯康星州格林贝市开设格林贝急救中心暨医院和在爱达荷州波士顿市开设波士顿急救中心暨医院后,这是公司在2024年的第三次开设。

"We are excited to provide concierge level medical care to the south Milwaukee market, which historically has been underserved," stated Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health.

“我们很高兴能为历史上服务不足的南密尔沃基市场提供礼宾级医疗服务,”Nutex Health董事长兼首席执行官Tom Vo万.D.表示。

About Nutex Health Inc.

关于Nutex Health公司

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.

Nutex Health公司成立于2011年,总部位于德克萨斯州休斯顿,是一家拥有医院部门和人群健康管理部门的医疗管理和运营公司。

The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in ten states.

医院部门拥有、开发并运营创新的医疗保健模式,包括微型医院、专科医院和医院门诊部(HOPDs)。该部门在十个州拥有并运营22家设施。

The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups.

人口健康管理部门拥有并运营提供者网络,如独立医师协会(IPAs)。通过我们的管理服务组织(MSO),我们为附属医院和医生团体提供管理、行政和其他支援服务。

Forward-Looking Statements

前瞻性声明

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and in the Quarterly Reports on Form 10-Q for the periods ending June 30, 2024 and September 31, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

本新闻稿中包含的某些声明和信息构成1995年《私人证券诉讼法》所指的“前瞻性声明”。在本新闻稿中使用的“将”、“可能会导致”、“预计”、“将继续”、“预期”、“估计”、“预计”、“打算”、“目标”或类似表达旨在识别1995年《私人证券诉讼改革法》内的“前瞻性声明”。这些声明受到某些已知和未知的风险和不确定性的影响,其中许多超出了公司的控制范围。这些不确定性和风险包括但不限于:我们成功执行增长策略的能力、法律或法规的变更,包括《无惊讶法》下实施的临时最终规则和最终规则、经济状况、对管理的依赖、对股东的稀释、缺乏资本、快速增长对公司的影响及管理层有效应对公司产品和服务的增长和需求的能力、新兴技术、公司的竞争能力、关联交易中的利益冲突、监管事务、技术保护、缺乏行业标准、竞争的影响以及公司获得未来融资的能力。影响未来业绩的各种因素在截至2023年12月31日的年度报告10-K以及截至2024年6月30日和2024年9月30日的季度报告10-Q中,按照“风险因素”标题进行了详细讨论,包含在第I部分,IA项中,以及其他不时提交给证券交易委员会的文件中。这些因素可能会对公司的财务表现产生重大不利影响,并可能导致公司未来期间的实际结果与本新闻稿中表达的任何意见或陈述有重大差异。

SOURCE Nutex Health, Inc.

SOURCE Nutex Health, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新闻在PRNEWSWIRE.COM上特色呈现吗?

440k+
440k+

Newsrooms &
新闻发布室&

Influencers
影响力人士
9k+
9k+

Digital Media
数字媒体

Outlets
Outlets
270k+
270k+

Journalists
记者

Opted In
Opted In
GET STARTED
开始使用
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发